EC Number   |
Title |
Organism |
|---|
    4.2.2.19 | Establishment of chondroitin B lyase-based analytical methods for sensitive and quantitative detection of dermatan sulfate in heparin |
Pedobacter heparinus |
| 4.2.2.19 | Establishment of chondroitin B lyase-based analytical methods for sensitive and quantitative detection of dermatan sulfate in heparin |
Pedobacter heparinus DSM 2366 |
| 4.2.2.19 | Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry |
Pedobacter heparinus |
| 4.2.2.19 | Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion |
Homo sapiens |
| 4.2.2.19 | Biochemical characterization of the chondroitinase B active site |
Pedobacter heparinus |
| 4.2.2.19 | Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution |
Pedobacter heparinus |
| 4.2.2.19 | Crystallization and preliminary X-ray analysis of chondroitinase B from Flavobacterium heparinum |
Pedobacter heparinus |
| 4.2.2.19 | Glycosaminoglycan degradation reduces mineralized tissue-titanium interfacial strength |
Pedobacter heparinus |
| 4.2.2.19 | Inhibition of hyaluronidases and chondroitinases by fatty acids |
Pedobacter heparinus |
| 4.2.2.19 | Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum |
Pedobacter heparinus |
